Bitterlich Norman, Schneider Joachim
Medizin und Service GmbH, Zwickauer Str. 227, D-09116 Chemnitz, Germany.
Anticancer Res. 2007 Jul-Aug;27(4A):1933-9.
The analysis of tumour markers is based on the evaluation of data in relation to defined cut-off values. Changes in the method of determination or reference study group have led to different results. Generally, fuzzy logic-based classifiers for the evaluation of tumour-marker profiles have increased sensitivity and higher specificity. Drawing from experiences with cut-off-oriented evaluation, the suggestion that diagnosis be made using a non-cut-off-based approach is discussed.
Two hundred and eighty-one consecutive patients with newly diagnosed, histologically confirmed lung cancer and a control group of 231 patients were examined. Histological classification of the tumour cases yielded 59 small cell carcinomas, 102 squamous cell carcinomas, 66 adenocarcinomas and 54 large cell carcinomas or mixed bronchial carcinomas without classification. The control group without tumours consisted of 23 healthy subjects, 125 patients with silicosis or asbestosis, 27 patients with chronic obstructive pulmonary diseases (COPD) and 56 persons suffered from inflammatory lung diseases.
CYFRA 21-1 was the most sensitive marker with a sensitivity of 57.3% and a specificity of 94.9%. The sensitivity increased when various tumour markers were evaluated. The loss of specificity through this type of multiparametric analysis could be compensated for by using a multiparametric evaluation such as a fuzzy logic classifier. A determination of the sensitivity-adapted confidence in diagnosis should be made. The decision guarantee and the cut-off-based evaluation are qualitatively equal because the decision threshold of 0.5 corresponds by definition to the cut-off value at 95% specificity. Every cut-off-based system of classification could be restated by using the decision guarantee instead of the measured values.
The evaluation based on decision guarantee has proven to be unaffected by changes in laboratory systems. The multiparametric system of classification based on decision guarantee of individual markers is self-adjusting and differences in measurement levels are eliminated if the ROC curves of the individual markers are in agreement.
肿瘤标志物的分析基于与既定临界值相关的数据评估。测定方法或参考研究组的变化导致了不同的结果。一般来说,基于模糊逻辑的肿瘤标志物谱评估分类器具有更高的灵敏度和特异性。借鉴基于临界值评估的经验,本文讨论了使用非基于临界值方法进行诊断的建议。
对281例新诊断、经组织学确诊的肺癌患者以及231例患者组成的对照组进行了检查。肿瘤病例的组织学分类包括59例小细胞癌、102例鳞状细胞癌、66例腺癌和54例大细胞癌或未分类的混合支气管癌。无肿瘤的对照组包括23名健康受试者、125例矽肺或石棉肺患者、27例慢性阻塞性肺疾病(COPD)患者和56例患有炎症性肺病的患者。
CYFRA 21-1是最敏感的标志物,灵敏度为57.3%,特异性为94.9%。当评估多种肿瘤标志物时,灵敏度有所提高。通过使用模糊逻辑分类器等多参数评估,可以弥补这种多参数分析导致的特异性损失。应确定对诊断的灵敏度适应性置信度。决策保证和基于临界值的评估在定性上是相等的,因为定义上0.5的决策阈值对应于95%特异性时的临界值。每个基于临界值的分类系统都可以通过使用决策保证而不是测量值来重新表述。
基于决策保证的评估已被证明不受实验室系统变化的影响。基于个体标志物决策保证的多参数分类系统是自我调整的,如果个体标志物的ROC曲线一致,则可以消除测量水平的差异。